Entrectinib for NTRK Fusion–Positive NSCLC: Updated Efficacy and Safety Data
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
Lung Cancer 2024 Feb 01;188(n/a)107442, BC Cho, CH Chiu, E Massarelli, GL Buchschacher, K Goto, TR Overbeck, HHF Loong, CE Chee, P Garrido, X Dong, Y Fan, S Lu, S Schwemmers, W Bordogna, H Zeuner, S Osborne, T JohnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.